Healthcare · Pharmaceuticals & Biotechnology
QVM read Mixed signals Quality Moderate, Valuation Fairly Valued, Momentum Neutral
Tradinity's own scoring, not a copy of any third party's -- see the Key Metrics section for the real ratios behind each number.
Tradinity's own yes/no questions with the rule stated beside each. “Items without enough data are left out, never counted as a No, and the totals count only answered questions. A summary of numbers on this page, not advice.
PE/EPS use each quarter's real filed EPS only from 45 days after quarter-end (no look-ahead) against the raw close of the day. Price-to-book isn't a mode here: the feed has no dated share count, so there's no real history to chart.
Prices adjusted for splits and bonuses. * = a corporate action affecting this date could not be parsed and is not reflected.
Week = 5 sessions, Month = 22 sessions ending the latest trading day — the same combined NSE+BSE delivery data as the table below, just summed.
Ranks #65 of 184 in Pharmaceuticals & Biotechnology by market cap -- full peer table on the Financials page.
| Filed | Person | Category | Type | Quantity | Value |
|---|---|---|---|---|---|
| 3 Apr 2022 | Alchemie Finserv Pvt. Ltd. | Promoter group | Buy | 0 | ₹0 |
| 3 Apr 2022 | Harit Pragji Shah | Director | Buy | 0 | ₹0 |
| 3 Apr 2022 | Renil Rajendra Gogri | Promoter group | Sell | 0 | ₹0 |
| 3 Apr 2022 | Harshit Manilal Savla | Promoter | Buy | 0 | ₹0 |
| 3 Apr 2022 | Seema Harshit Savla | Promoter group | Buy | 0 | ₹0 |
| 3 Apr 2022 | Prakash Moreshwar Patil | Promoter | Buy | 0 | ₹0 |
| 1 Apr 2022 | Renil Rajendra Gogri | Director | Sell | 0 | ₹0 |
| 1 Apr 2022 | Alchemie Finserv Pvt. Ltd. | Promoter group | Buy | 0 | ₹0 |
| 1 Apr 2022 | Rashesh Chandrakant Gogri | Director | Buy | 0 | ₹0 |
| 8 Mar 2022 | Arun Moreshwar Patil | Promoter group | Buy | 0 | ₹0 |
| Date | Client | Deal | Action | Quantity | Price | Exchange |
|---|---|---|---|---|---|---|
| 7 May 2025 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 803,687 | 393.6200 | NSE |
| 7 May 2025 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 803,477 | 393.1000 | NSE |
| 28 May 2024 | MIRIK RAJENDRA GOGRI | Bulk | Sell | 468,378 | 485.5000 | NSE |
| 28 May 2024 | BLEND FUND 2 | Bulk | Buy | 511,571 | 484.9700 | NSE |
| 18 Oct 2023 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 480,077 | 554.1700 | NSE |
| 18 Oct 2023 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 480,077 | 554.7000 | NSE |
| 25 Jul 2023 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Sell | 933,060 | 628.4000 | NSE |
| 25 Jul 2023 | GRAVITON RESEARCH CAPITAL LLP | Bulk | Buy | 933,060 | 627.8900 | NSE |
| 24 Jul 2023 | QE SECURITIES | Bulk | Sell | 505,851 | 587.7300 | NSE |
| 24 Jul 2023 | QE SECURITIES | Bulk | Buy | 497,273 | 587.7700 | NSE |
| Ex-date | Subject | Per share (₹) | Record date |
|---|---|---|---|
| 9 Feb 2026 | Interim Dividend - Rs 2 Per Share | 2.0000 | 9 Feb 2026 |
| 4 Feb 2025 | Interim Dividend - Re 1 Per Share | 1.0000 | 4 Feb 2025 |
| 6 Feb 2024 | Interim Dividend - Re 1 Per Share | 1.0000 | 6 Feb 2024 |
| 8 Feb 2023 | Interim Dividend - Rs 1 Per Share | 1.0000 | 8 Feb 2023 |
| 9 Feb 2022 | Interim Dividend - Re 1 Per Share | 1.0000 | 10 Feb 2022 |
| 3 Nov 2020 | Interim Dividend - Rs 2.5 Per Share | 2.5000 | 4 Nov 2020 |
| 17 Feb 2020 | Interim Dividend - Rs 2 Per Share | 2.0000 | 18 Feb 2020 |
| 26 Jul 2019 | Annual General Meeting/Dividend - Re 1 Per Share | 1.0000 | — |
| 1 Aug 2018 | Annual General Meeting/Dividend- Re 1 Per Share | 1.0000 | — |
| 9 Aug 2017 | Annual General Meeting/Dividend - Re 1/- Per Share | 1.0000 | — |
Bonuses, splits, buybacks and other events. Dividends are listed separately above.
| Ex-date | Type | Subject |
|---|---|---|
| 30 Sep 2020 | BONUS | Bonus 3:1 |
| 24 Mar 2015 | BONUS | Bonus 1:1 |
| 5 Sep 2024 | BUYBACK | Buy Back |
| 4 Aug 2023 | BUYBACK | Buy Back |
| 30 Mar 2021 | BUYBACK | Buyback |
| 28 Mar 2019 | BUYBACK | Buyback |
| 18 Jan 2018 | BUYBACK | Buyback |
Quarterly results, AGMs, buybacks and other board-approved business.
| Date | Purpose | Results |
|---|---|---|
| 27 Aug 2026 | Other business matters | — |
| 31 Jul 2026 | Financial Results | Yes |
| 15 May 2026 | Financial Results | Yes |
| 3 Feb 2026 | Financial Results/Dividend | Yes |
| 7 Nov 2025 | Financial Results | Yes |
Exchange disclosures (NSE and BSE), most recent first.
Tradinity's own rule-based read of the real ratios elsewhere on this page -- not a copy of any third party's, and never a forward-looking prediction.
Data unavailable.
Data unavailable.
Board of directors and corporate information →
Data unavailable (no single-stock futures or options activity on record for this company).
The price at the top of this page is the last traded price from exchange data; during market hours it refreshes on its own. The Chart & Technicals section has the full price history.
The Financials page has quarterly and annual results, ratios, cash flow and the balance sheet, on a standalone or consolidated basis.
The Ownership section shows the latest shareholding pattern from exchange filings, with promoter, FII, DII and public holdings by quarter.
No. The scores and checklist on this page are rule-based summaries of published figures, not recommendations. Tradinity is not a registered investment adviser.
